Literature DB >> 28695919

Kidney cancer: Savolitinib - a saviour for papillary RCC?

Annette Fenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28695919     DOI： 10.1038/nrurol.2017.114

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer.

Authors:  Toni K Choueiri; Elizabeth Plimack; Hendrik-Tobias Arkenau; Eric Jonasch; Daniel Y C Heng; Thomas Powles; Melanie M Frigault; Edwin A Clark; Amir A Handzel; Humphrey Gardner; Shethah Morgan; Laurence Albiges; Sumanta Kumar Pal
Journal:  J Clin Oncol       Date:  2017-06-23       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.